Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL709188

CC(C)Oc1cc(OCc2ccncc2)cc(-c2nc3cccnc3[nH]2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCK P35557 3/20 0.39
DHODH Q02127 2/20 0.39
NOS1 P29475 2/20 0.38
MCL1 Q07820 1/20 0.37
NOS3 P29474 1/20 0.36
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
MAOB P27338 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GPR132 Q9UNW8 2/20 0.35
ADAMTS4 O75173 1/20 0.35
MMP13 P45452 1/20 0.35
CHEK2 O96017 1/20 0.35
PDE4B Q07343 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CBFB Q13951 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL713011 0.95 GCK (0.44) GCKDHODHNOS1MCL1NOS3
Trifluoroacetic Acid SCHEMBL709569 0.92 DHODH (0.43) GCKDHODHL3MBTL1GPR132ADAMTS4
SCHEMBL10206658 0.91 NOS3 (0.38) GCKDHODHNOS1MCL1NOS3
Trifluoroacetic Acid SCHEMBL709921 0.89 GCK (0.43) GCKNOS1PDE4B
Trifluoroacetic Acid SCHEMBL712377 0.87 CHEK2 (0.45) DHODHCHEK2
Trifluoroacetic Acid SCHEMBL709930 0.86 GCK (0.48) GCKMAOBCBFB
Trifluoroacetic Acid SCHEMBL720615 0.86 GCK (0.45) GCKPDE4BCBFB
SCHEMBL709496 0.86 PRMT5 (0.44) GCKMCL1CHEK2CBFB
Trifluoroacetic Acid SCHEMBL711040 0.85 DHODH (0.45) DHODHL3MBTL1GPR132MMP13CHEK2
Trifluoroacetic Acid SCHEMBL710197 0.85 MAOB (0.36) DHODHMCL1CTSLCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940837-B1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL (JP) 2012-11-07 EP disclosed
US-8124617-B2 Imidazopyridine compounds TAKEDA SAN DIEGO, INC. (US) 2012-02-28 US disclosed
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS TAKEDA SAN DIEGO, INC. 2010-03-18 US disclosed
EP-1940837-A2 IMIDAZOPYRIDINE COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2008-07-09 EP disclosed
WO-2007028135-A2 IMIDAZOPYRIDINE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069431-A1 IMIDAZOPYRIDINE COMPOUNDS GCK, GCKR, KHK GCK 1/4885DHODH 910/4885NOS1 3126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.